Dr. Shannon Sauer-Zavala, PhD

Claim this profile
Studies Suicidal Thoughts
Studies Depression
1 reported clinical trial
1 drug studied

Clinical Trials Shannon Sauer-Zavala, PhD is currently running

Image of trial facility.

Single-Session Intervention

for Suicidal Thoughts

Across multiple models of suicide risk, hopelessness and perceptions of social relatedness (i.e., lack of social connection/thwarted belongingness, perceived burdensomeness) have emerged as candidate mechanisms that maintain STBs. Although these mechanisms have garnered strong empirical support in predicting STBs, there has been virtually no integration with interventions aimed for individuals at acute risk for suicide. Thus, the overarching goal of the present proposal is to evaluate a mechanism-focused intervention that explicitly targets two core mechanisms implicated in the maintenance of STBs: hopelessness and negative perceptions of social relatedness. Given that the period immediately following hospital discharge presents the highest risk for suicide attempts and up to 70% of patients admitted for a suicide attempt do not attend their first outpatient appointment, the intervention will be evaluated on an inpatient unit. Additionally, most of the extant interventions for STBs are administered across multiple sessions (i.e., 4 sessions and up to one year); however treatments of this length are unlikely to be feasible in acute care settings. Fortunately, very brief suicide prevention interventions, are effective in reducing future suicide attempts and increasing the likelihood of attending follow-up treatments. Additionally, single-session interventions (not suicide specific) have been shown to reduce hopelessness immediately and at a one-month follow-up. The present study is an RCT comparing a novel Single Session Mechanism Focused Intervention (SSMFI) for STBs to treatment-as-usual (TAU) on a psychiatric inpatient unit for patients admitted for suicidal ideation or attempt. The engagement of the putative processes (hopelessness and negative perceptions of social relatedness) that maintain STBs will be assessed, along with the feasibility and acceptability of SSMFI for STBs on an inpatient psychiatric unit.
Recruiting1 award N/A3 criteria

More about Shannon Sauer-Zavala, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Shannon Sauer-Zavala, PhD has experience with
  • Single-Session Mechanism-Focused Intervention (SSMFI)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shannon Sauer-Zavala, PhD specialize in?
Shannon Sauer-Zavala, PhD focuses on Suicidal Thoughts and Depression. In particular, much of their work with Suicidal Thoughts has involved treating patients, or patients who are undergoing treatment.
Is Shannon Sauer-Zavala, PhD currently recruiting for clinical trials?
Yes, Shannon Sauer-Zavala, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Shannon Sauer-Zavala, PhD has studied deeply?
Yes, Shannon Sauer-Zavala, PhD has studied treatments such as Single-Session Mechanism-Focused Intervention (SSMFI).
What is the best way to schedule an appointment with Shannon Sauer-Zavala, PhD?
Apply for one of the trials that Shannon Sauer-Zavala, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.